-

$undefined

N/A

(N/A)

Disc Medicine Inc :IRON

Location: | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

1.137B

Cash

487.4M

Avg Qtr Burn

-21.04M

Short % of Float

10.34%

Insider Ownership

11.45%

Institutional Own.

80.76%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Bitopertin (GlyT1 inhibitor) Details
erythropoietic porphyrias, X-linked protoporphyria

NDA

Submission

DISC-0974 Details
Myelofibrosis, Anemia, Chronic kidney disease

Phase 2

Data readout

DISC-3405 (formerly MWTX-003) Details
Polycythemia vera, Cancer, Blood cancer

Phase 2

Initiation

Bitopertin (GlyT1 inhibitor) Details
Anemia, Rare genetic disease

Phase 1/2

Update

GEM103 Details
Age-related macular degeneration

Failed

Discontinued

GEM103 Details
Wet age-related macular degeneration , Age-related macular degeneration

Failed

Discontinued